---
title: "Tianyi Medical issued a profit warning, expecting an annual net loss of RMB 461,000 to RMB 768,300"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/226164725.md"
description: "According to the Zhitong Finance APP, Tianyi Medical disclosed its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of RMB 461,000 to RMB 768,300; the net loss after deducting non-recurring gains and losses is expected to be RMB 8.0435 million to RMB 13.4059 million"
datetime: "2025-01-24T13:09:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/226164725.md)
  - [en](https://longbridge.com/en/news/226164725.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/226164725.md)
generator: "portal-rs"
---

# Tianyi Medical issued a profit warning, expecting an annual net loss of RMB 461,000 to RMB 768,300

According to the Zhitong Finance APP, Tianyi Medical (301097.SZ) disclosed its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of RMB 461,000 to RMB 768,300; the net loss after deducting non-recurring gains and losses is expected to be RMB 8.0435 million to RMB 13.4059 million

### Related Stocks

- [301097.CN](https://longbridge.com/en/quote/301097.CN.md)

## Related News & Research

- [08:27 ETClose O Matic's Step Six: How AI Sales Conversations Become Closed Sales](https://longbridge.com/en/news/297517308.md)
- [Cupid share price in focus on board approval to set up manufacturing venture in South African](https://longbridge.com/en/news/297455298.md)
- [RBI's plastic note plan draws Cosmo First, CCL Secure; no animal tallow, China-Pakistan firewall mandatory: Report](https://longbridge.com/en/news/297456921.md)
- [PALS: PhotonAssay™ labs deliver rapid, scalable assay solutions amid surging mining sector demand](https://longbridge.com/en/news/297524125.md)
- [Trailbreaker Resources Mobilizes To Coho Property For Inaugural Diamond Drill Program](https://longbridge.com/en/news/297511517.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**